Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Baseline characteristics of the study cohort

From: Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort study

Variable Immunologic treatment failure Total (%)
Yes (%) No (%)  
Sex Male 32 (17.0) 156 (83.0) 188 (64.2)
Female 14 (13.6) 89 (86.4) 103 (35.2)
NR 1 (50.0) 1(50.0) 2 (0.7)
Age (In years), at Month0 Mean, SD 34.6, 7.5 36.6, 8.5 36.7, 8.6
15–34 23 (18.1) 104 (81.9) 127 (43.5)
35–44 16 (13.3) 104 (86.7) 120 (41.1)
> = 45 6 (13.3) 39 (86.7) 45 (15.4)
Original First Line Regimen D4T/3TC/NVP 15 (13.0) 100 (87.0) 115 (39.2)
D4T/3TC/EFV 59 (78.7) 16 (21.3) 75 (25.6)
AZT/3TC/NVP 32 (78.0) 9 (22.0) 41 (14.0)
AZT/3TC/EFV 54 (91.5) 5 (8.5) 59 (20.1)
TDF/3TC/EFV 2 (66.7) 1 (33.3) 3 (1.0)
Original Regimen substituted Yes 34 (16.8) 168 (83.2) 202 (68.9)
No 79 (87.8) 11 (12.2) 90 (30.7)
NR 0 1 1 (0.3)
Switch to second line regimen Yes 2 (33.3) 4 (66.7) 6 (2.0)
No 44 (15.3) 243 (84.7) 287 (98.0)
Baseline CD4 count, cells/mm3 Median, IQR 122 (67–190) 114 (63–176) 115 (64–176)
0–49 6 (12.8) 41 (87.2) 47 (16.2)
50–99 12 (16.0) 63 (84.0) 75 (25.9)
100–149 9 (14.3) 54 (85.7) 63 (21.7)
150–199 8 (12.9) 54 (87.1) 62 (21.4)
> = 200 10 (23.3) 33 (76.7) 43 (14.8)
Base line functional status Work 29 (15.9) 153 (84.1) 182 (62.1)
Ambulatory 9 (15.5) 49 (84.5) 58 (19.8)
Bedridden 3 (12.0) 22 (88.0) 25 (8.5)
NR 5 (17.9) 23 (82.1) 28 (9.6)
Body Mass Index. Kg/m2 <18.5 12 (18.8) 52 (81.2) 64 (21.8)
> = 18.5 15 (13.9) 93 (86.1) 108 (36.9)
NR 19 (15.7) 102 (84.3) 121 (41.3)
Gap between testing and treatment initiation Same month 29 (17.0) 142 (83.0) 171 (59.0)
1–24 months 13 (13.4) 84 (86.6) 97 (33.4)
>24 months 4 (18.2) 18 (81.8) 22 (7.6)
Adherence Good 35 (15.2) 195 (84.8) 230 (78.5)
Fair/ poor 10 (18.5) 44 (81.5) 54 (18.4)
NR 1 (11.1) 8 (88.9) 9 (3.1)
  1. NR Not Recorded, IQR Interquartile Range, SD Standard Deviation